Home > Insider Trading > Filing (0001177648-20-000001)

Filing Details

Accession Number:: 0001177648-20-000001
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-01-06 18:17:50
Reporting Period:: 2019-12-16

Accepted Time:: 2020-01-06 18:17:50
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1177648	Enanta Pharmaceuticals Inc	ENTA	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1185034	J Paul Mellett	C/O Enanta Pharmaceuticals, Inc. 500 Arsenal Street Watertown MA 02472	Treasurer And Cfo	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2019-12-16	2,625	$0.00	51,219	No	4	M	Direct
Common Stock	Disposition	2019-12-16	1,165	$63.88	50,054	No	4	F	Direct
Common Stock	Disposition	2020-01-02	9,279	$60.82	40,775	No	4	S	Direct
Common Stock	Disposition	2020-01-02	721	$61.66	40,054	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	F	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Units	Disposition	2019-12-16	2,625	$0.00	2,625	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
2,625			No	4	M	Direct

Footnotes

Represents shares of ENTA common stock subject to a restricted stock unit award granted on November 18, 2016 that vested on November 18, 2019. The settlement and issuance of the shares was subject to continued employment and occurred on December 16, 2019.
Restricted stock units convert into ENTA common stock on a one-for-one basis.
Since the date of the reporting person's last ownership report, he transferred 48,594 shares of ENTA common stock and 5,250 restricted stock units (which convert into ENTA common stock on a one-for-one basis) to his ex-wife pursuant to a domestic relations order. The reporting person no longer reports as beneficially owned any securities owned by his ex-wife.
Represents the number of shares of ENTA common stock forfeited by the reporting person to cover withholding taxes due as a result of settlement of the restricted stock unit award.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2019.
The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $60.39 to $61.31, inclusive.
The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $60.40 to $62.09, inclusive.
On November 18, 2016, the reporting person was granted 10,500 restricted stock units. 5,250 restricted stock units vested on November 18, 2019 and the remainder will vest on November 18, 2020, subject to the reporting person's continued employment. As noted in footnote 3 above, 5,250 of the restricted stock units were transferred to the reporting person's ex-wife pursuant to a domestic relations order and the reporting person no longer reports as beneficially owned any securities owned by his ex-wife.